Skip to main content

US ClosedU.S. Closed

GUTS: Fractyl Health, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Fractyl Health, Inc. , a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.

52W Range

14thpctl

Volume

1.30×avg

Market Cap

104.55MUSD

P/E Ratio

-0.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Fractyl Health, Inc.

GUTSNASDAQ·USD·Closed

Fractyl Health, Inc.

GUTSNASDAQ·USD·Closed

$0.66

−11.16%

$0.66

−$0.08 (11.16%)

52W Range

14thpctl

Volume

1.30×avg

Mkt Cap

104.55MUSD

P/E

-0.6TTM

Div Yield

–ann